Pathstone Holdings
ASTH icon

Pathstone Holdings’s Astrana Health ASTH Stock Holding History

Pathstone Holdings’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-16,736
Closed -$474K – 2416
2025
Q3 		$474K Buy
16,736
+5,449
+48% +$148K ﹤0.01% 1801
2025
Q2 		$281K Sell
11,287
-1,866
-14% -$52.6K ﹤0.01% 1946
2025
Q1 		$408K Buy
13,153
+3,649
+38% +$122K ﹤0.01% 1806
2024
Q4 		$300K Buy
9,504
+3,318
+54% +$158K ﹤0.01% 1968
2024
Q3 		$358K Buy
+6,186
New +$304K ﹤0.01% 1897

Other funds holding ASTH

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.8B AUM 48.92% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return